Transgene
France - Illkirch-Graffenstaden
BiotechnologyFocus: Viral Vector Therapeutics, Gene Therapy
Transgene is a life sciences company focused on Viral Vector Therapeutics, Gene Therapy.
Gene Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
blood draw
Chronic Hepatitis BClinical Trials (1)
NCT02355951Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection
N/AMVA-FCU1, flucytosine
Hepatocellular CarcinomaClinical Trials (1)
NCT00978107Trial of TG4023 Combined With Flucytosine in Liver Tumors
Phase 1TG1050
Chronic Hepatitis BClinical Trials (1)
NCT02428400Safety and Tolerability of TG1050: A Dose-finding Study
Phase 1Pexa-Vec
Metastatic TumorClinical Trials (1)
NCT02977156Immunization Strategy With Intra-tumoral Injections of Pexa-Vec With Ipilimumab in Metastatic / Advanced Solid Tumors.
Phase 1Phase 1
Clinical Trials (1)
NCT05788926A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)
Phase 1MVA-HCV
Hepatitis C, ChronicClinical Trials (1)
NCT00529321Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus
Phase 1TG4050
Ovarian CarcinomaClinical Trials (1)
NCT03839524A Trial Evaluating TG4050 in Ovarian Carcinoma.
Phase 1Combination of TG6002 and 5-flucytosine
GlioblastomaClinical Trials (1)
NCT03294486Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients
Phase 1/2Cyclophosphamide and JX-594 dose escalation
Solid TumorsTG6002
Colorectal NeoplasmsClinical Trials (1)
NCT04194034Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer
Phase 1/2JX-594
Colorectal CarcinomaClinical Trials (1)
NCT01394939Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT04183166A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
Phase 1/2Pexastimogene Devacirepvec
Hepatocellular Carcinoma (HCC)Clinical Trials (1)
NCT03071094A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)
Phase 1/2TG6002
Colorectal NeoplasmClinical Trials (1)
NCT03724071Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors.
Phase 1/2BT-001
Metastatic CancerTG4001
HPV-Related CarcinomaPhase 2
pegylated interferon and ribavirin
Chronic Hepatitis C InfectionClinical Trials (1)
NCT01055821Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients
Phase 2MVA-MUC1-IL2
Prostatic NeoplasmsClinical Trials (1)
NCT00040170Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer
Phase 2Adenovirus Interferon gamma
Lymphoma, B-CellClinical Trials (1)
NCT00394693Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma
Phase 2Phase 2
MVA-MUC1-IL2
Carcinoma, Non-Small-Cell LungClinical Trials (1)
NCT00415818Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer
Phase 2/3Phase 2/3
Clinical Trials (1)
NCT01383148Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
Phase 2/3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2008
Portfolio: 18 clinical trials